04.18.13
Aptiv Solutions has established an Adaptive Center of Excellence (ACOE) to further the development of the company’s strategic partnerships with three top global pharma companies. These three companies have also agreed to join a consortium organized by Aptiv Solutions to develop and implement new methodologies for adaptive dose-finding trials.
The ACOE will focus on defining, developing and implementing new execution models for adaptive clinical trials. The ACOE will be led by Michael McKelvey, Ph.D., chief operating officer and Reinhard Eisebitt, executive vice president of the Aptiv Solutions Innovation Center and managing director of ADDPLAN, Aptiv’s statistical software subsidiary. The ACOE is comprised of a group of 15 senior-level individuals from various Aptiv departments.
The goal of the ACOE is to address trial execution challenges for sophisticated adaptive designs that will have a favorable impact on efficiency and productivity, as well as reduce trial setup time, introduce improved site selection and patient enrollment strategies, and advance data-driven monitoring techniques.
“The main challenge we see is to synchronize the design and the execution of adaptive trials which will bring significant productivity benefits to the product development process,” said Patrick Donnelly, chairman and chief executive officer at Aptiv Solutions. “We believe that the ACOE will provide innovative ways to achieve this and we look forward to working with our valued clients on some very exciting joint projects.”
The ACOE will focus on defining, developing and implementing new execution models for adaptive clinical trials. The ACOE will be led by Michael McKelvey, Ph.D., chief operating officer and Reinhard Eisebitt, executive vice president of the Aptiv Solutions Innovation Center and managing director of ADDPLAN, Aptiv’s statistical software subsidiary. The ACOE is comprised of a group of 15 senior-level individuals from various Aptiv departments.
The goal of the ACOE is to address trial execution challenges for sophisticated adaptive designs that will have a favorable impact on efficiency and productivity, as well as reduce trial setup time, introduce improved site selection and patient enrollment strategies, and advance data-driven monitoring techniques.
“The main challenge we see is to synchronize the design and the execution of adaptive trials which will bring significant productivity benefits to the product development process,” said Patrick Donnelly, chairman and chief executive officer at Aptiv Solutions. “We believe that the ACOE will provide innovative ways to achieve this and we look forward to working with our valued clients on some very exciting joint projects.”